25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

The Biotech Growth Trust PLC
Buy, Hold or Sell?

Let's analyze The Biotech Growth Trust PLC together

I guess you are interested in The Biotech Growth Trust PLC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of The Biotech Growth Trust PLC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about The Biotech Growth Trust PLC

I send you an email if I find something interesting about The Biotech Growth Trust PLC.

1. Quick Overview

1.1. Quick analysis of The Biotech Growth Trust PLC (30 sec.)










1.2. What can you expect buying and holding a share of The Biotech Growth Trust PLC? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
p1,002.48
Expected worth in 1 year
p1,733.05
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
p730.58
Return On Investment
80.9%

For what price can you sell your share?

Current Price per Share
p903.00
Expected price per share
p827.00 - p949.28
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of The Biotech Growth Trust PLC (5 min.)




Live pricePrice per Share (EOD)
p903.00
Intrinsic Value Per Share
p-170.04 - p194.07
Total Value Per Share
p832.43 - p1,196.55

2.2. Growth of The Biotech Growth Trust PLC (5 min.)




Is The Biotech Growth Trust PLC growing?

Current yearPrevious yearGrowGrow %
How rich?$458.2m$418.9m$39.3m8.6%

How much money is The Biotech Growth Trust PLC making?

Current yearPrevious yearGrowGrow %
Making money$94.6m-$52.3m$146.9m155.4%
Net Profit Margin95.6%109.7%--

How much money comes from the company's main activities?

2.3. Financial Health of The Biotech Growth Trust PLC (5 min.)




2.4. Comparing to competitors in the Asset Management industry (5 min.)




  Industry Rankings (Asset Management)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of The Biotech Growth Trust PLC?

Welcome investor! The Biotech Growth Trust PLC's management wants to use your money to grow the business. In return you get a share of The Biotech Growth Trust PLC.

First you should know what it really means to hold a share of The Biotech Growth Trust PLC. And how you can make/lose money.

Speculation

The Price per Share of The Biotech Growth Trust PLC is p903.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of The Biotech Growth Trust PLC.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in The Biotech Growth Trust PLC, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p1,002.48. Based on the TTM, the Book Value Change Per Share is p182.64 per quarter. Based on the YOY, the Book Value Change Per Share is p-131.41 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of The Biotech Growth Trust PLC.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps2.630.3%2.630.3%-1.30-0.1%0.640.1%0.670.1%
Usd Book Value Change Per Share2.320.3%2.320.3%-1.67-0.2%0.640.1%0.640.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2.320.3%2.320.3%-1.67-0.2%0.640.1%0.640.1%
Usd Price Per Share12.62-12.62-9.93-12.47-10.75-
Price to Earnings Ratio4.81-4.81--7.64-0.84-1.40-
Price-to-Total Gains Ratio5.45-5.45--5.96-2.77-19.58-
Price to Book Ratio0.99-0.99-0.96-0.97-0.96-
Price-to-Total Gains Ratio5.45-5.45--5.96-2.77-19.58-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.452749
Number of shares87
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share2.320.64
Usd Total Gains Per Share2.320.64
Gains per Quarter (87 shares)201.5355.45
Gains per Year (87 shares)806.14221.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
108067960222212
20161216020444434
30241824080665656
40322532140887878
5040314020011091100
6048374826013311322
7056435632015531544
8064496438017751766
9072557244019961988
10080618050022182210

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%6.04.00.060.0%9.04.00.069.2%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%6.04.00.060.0%9.04.00.069.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%6.04.00.060.0%9.04.00.069.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of The Biotech Growth Trust PLC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--182.645182.6450%-131.408+172%50.257+263%50.296+263%
Book Value Per Share--1002.4751002.4750%819.830+22%1017.008-1%879.339+14%
Current Ratio--99.63599.6350%0.109+91692%19.989+398%10.254+872%
Debt To Asset Ratio--0.1220.1220%0.084+45%0.089+37%0.079+54%
Debt To Equity Ratio--0.1390.1390%0.091+52%0.098+41%0.087+60%
Dividend Per Share----0%-0%-0%-0%
Eps--206.984206.9840%-102.508+150%50.276+312%52.826+292%
Free Cash Flow Per Share---11.767-11.7670%-14.620+24%-16.142+37%-11.382-3%
Free Cash Flow To Equity Per Share---63.765-63.7650%-106.539+67%-68.342+7%-53.199-17%
Gross Profit Margin--0.9990.9990%1.0020%1.0000%1.0000%
Intrinsic Value_10Y_max--194.071--------
Intrinsic Value_10Y_min---170.040--------
Intrinsic Value_1Y_max---4.746--------
Intrinsic Value_1Y_min---18.999--------
Intrinsic Value_3Y_max--4.178--------
Intrinsic Value_3Y_min---55.725--------
Intrinsic Value_5Y_max--35.331--------
Intrinsic Value_5Y_min---90.680--------
Market Cap28575164100.000-25%35861288520.00035861288520.0000%31545287892.000+14%39696935238.400-10%40859297647.850-12%
Net Profit Margin--0.9560.9560%1.097-13%0.990-3%0.994-4%
Operating Margin--1.9391.9390%1.116+74%1.190+63%1.507+29%
Operating Ratio--0.1010.1010%-0.236+334%-0.045+145%-0.060+159%
Pb Ratio0.901-10%0.9930.9930%0.955+4%0.969+2%0.965+3%
Pe Ratio4.363-10%4.8074.8070%-7.638+259%0.843+470%1.396+244%
Price Per Share903.000-10%995.000995.0000%783.000+27%983.200+1%847.850+17%
Price To Free Cash Flow Ratio-76.740+9%-84.559-84.5590%-53.557-37%-72.923-14%4.387-2028%
Price To Total Gains Ratio4.944-10%5.4485.4480%-5.959+209%2.773+96%19.583-72%
Quick Ratio--99.63599.6350%0.108+92283%20.026+398%10.272+870%
Return On Assets--0.1810.1810%-0.115+163%0.011+1592%0.031+484%
Return On Equity--0.2060.2060%-0.125+161%0.014+1423%0.033+528%
Total Gains Per Share--182.645182.6450%-131.408+172%50.257+263%50.296+263%
Usd Book Value--458245668.100458245668.1000%418908075.300+9%520724916.360-12%537682975.170-15%
Usd Book Value Change Per Share--2.3162.3160%-1.667+172%0.637+263%0.638+263%
Usd Book Value Per Share--12.71412.7140%10.398+22%12.899-1%11.153+14%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--2.6252.6250%-1.300+150%0.638+312%0.670+292%
Usd Free Cash Flow---5378860.300-5378860.3000%-7470287.000+39%-8308886.706+54%-6563325.543+22%
Usd Free Cash Flow Per Share---0.149-0.1490%-0.185+24%-0.205+37%-0.144-3%
Usd Free Cash Flow To Equity Per Share---0.809-0.8090%-1.351+67%-0.867+7%-0.675-17%
Usd Market Cap362418806.280-25%454828722.299454828722.2990%400088886.334+14%503476229.629-10%518218472.068-12%
Usd Price Per Share11.453-10%12.62012.6200%9.931+27%12.470+1%10.753+17%
Usd Profit--94615180.00094615180.0000%-52378253.400+155%23389481.280+305%33880732.050+179%
Usd Revenue--98926131.70098926131.7000%-47756568.200+148%25081647.140+294%35932968.280+175%
Usd Total Gains Per Share--2.3162.3160%-1.667+172%0.637+263%0.638+263%
 EOD+3 -5MRQTTM+0 -0YOY+26 -85Y+21 -1310Y+18 -16

3.3 Fundamental Score

Let's check the fundamental score of The Biotech Growth Trust PLC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-154.363
Price to Book Ratio (EOD)Between0-10.901
Net Profit Margin (MRQ)Greater than00.956
Operating Margin (MRQ)Greater than01.939
Quick Ratio (MRQ)Greater than199.635
Current Ratio (MRQ)Greater than199.635
Debt to Asset Ratio (MRQ)Less than10.122
Debt to Equity Ratio (MRQ)Less than10.139
Return on Equity (MRQ)Greater than0.150.206
Return on Assets (MRQ)Greater than0.050.181
Total10/10 (100.0%)

3.4 Technical Score

Let's check the technical score of The Biotech Growth Trust PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.376
Ma 20Greater thanMa 50995.300
Ma 50Greater thanMa 1001,017.840
Ma 100Greater thanMa 2001,014.850
OpenGreater thanClose887.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About The Biotech Growth Trust PLC

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.

Fundamental data was last updated by Penke on 2024-11-01 17:18:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit The Biotech Growth Trust PLC earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare The Biotech Growth Trust PLC to the Asset Management industry mean.
  • A Net Profit Margin of 95.6% means that 0.96 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of The Biotech Growth Trust PLC:

  • The MRQ is 95.6%. The company is making a huge profit. +2
  • The TTM is 95.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ95.6%TTM95.6%0.0%
TTM95.6%YOY109.7%-14.0%
TTM95.6%5Y99.0%-3.4%
5Y99.0%10Y99.4%-0.4%
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
MRQ95.6%55.4%+40.2%
TTM95.6%53.9%+41.7%
YOY109.7%62.6%+47.1%
5Y99.0%56.1%+42.9%
10Y99.4%54.0%+45.4%
4.3.1.2. Return on Assets

Shows how efficient The Biotech Growth Trust PLC is using its assets to generate profit.

  • Above 5% is considered healthy but always compare The Biotech Growth Trust PLC to the Asset Management industry mean.
  • 18.1% Return on Assets means that The Biotech Growth Trust PLC generated 0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of The Biotech Growth Trust PLC:

  • The MRQ is 18.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 18.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ18.1%TTM18.1%0.0%
TTM18.1%YOY-11.5%+29.6%
TTM18.1%5Y1.1%+17.1%
5Y1.1%10Y3.1%-2.0%
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
MRQ18.1%1.4%+16.7%
TTM18.1%1.5%+16.6%
YOY-11.5%0.8%-12.3%
5Y1.1%1.7%-0.6%
10Y3.1%1.9%+1.2%
4.3.1.3. Return on Equity

Shows how efficient The Biotech Growth Trust PLC is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare The Biotech Growth Trust PLC to the Asset Management industry mean.
  • 20.6% Return on Equity means The Biotech Growth Trust PLC generated 0.21 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of The Biotech Growth Trust PLC:

  • The MRQ is 20.6%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 20.6%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ20.6%TTM20.6%0.0%
TTM20.6%YOY-12.5%+33.2%
TTM20.6%5Y1.4%+19.3%
5Y1.4%10Y3.3%-1.9%
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
MRQ20.6%2.5%+18.1%
TTM20.6%2.7%+17.9%
YOY-12.5%1.7%-14.2%
5Y1.4%2.6%-1.2%
10Y3.3%3.0%+0.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of The Biotech Growth Trust PLC.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient The Biotech Growth Trust PLC is operating .

  • Measures how much profit The Biotech Growth Trust PLC makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare The Biotech Growth Trust PLC to the Asset Management industry mean.
  • An Operating Margin of 193.9% means the company generated 1.94  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of The Biotech Growth Trust PLC:

  • The MRQ is 193.9%. The company is operating very efficient. +2
  • The TTM is 193.9%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ193.9%TTM193.9%0.0%
TTM193.9%YOY111.6%+82.3%
TTM193.9%5Y119.0%+74.9%
5Y119.0%10Y150.7%-31.8%
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
MRQ193.9%84.7%+109.2%
TTM193.9%71.5%+122.4%
YOY111.6%52.5%+59.1%
5Y119.0%48.0%+71.0%
10Y150.7%48.1%+102.6%
4.3.2.2. Operating Ratio

Measures how efficient The Biotech Growth Trust PLC is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Asset Management industry mean).
  • An Operation Ratio of 0.10 means that the operating costs are 0.10 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of The Biotech Growth Trust PLC:

  • The MRQ is 0.101. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.101. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.101TTM0.1010.000
TTM0.101YOY-0.236+0.337
TTM0.1015Y-0.045+0.146
5Y-0.04510Y-0.060+0.014
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1010.445-0.344
TTM0.1010.465-0.364
YOY-0.2360.592-0.828
5Y-0.0450.551-0.596
10Y-0.0600.569-0.629
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of The Biotech Growth Trust PLC.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if The Biotech Growth Trust PLC is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Asset Management industry mean).
  • A Current Ratio of 99.63 means the company has 99.63 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of The Biotech Growth Trust PLC:

  • The MRQ is 99.635. The company is very able to pay all its short-term debts. +2
  • The TTM is 99.635. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ99.635TTM99.6350.000
TTM99.635YOY0.109+99.526
TTM99.6355Y19.989+79.646
5Y19.98910Y10.254+9.736
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
MRQ99.6352.870+96.765
TTM99.6353.301+96.334
YOY0.1093.718-3.609
5Y19.9895.130+14.859
10Y10.2547.379+2.875
4.4.3.2. Quick Ratio

Measures if The Biotech Growth Trust PLC is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare The Biotech Growth Trust PLC to the Asset Management industry mean.
  • A Quick Ratio of 99.63 means the company can pay off 99.63 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of The Biotech Growth Trust PLC:

  • The MRQ is 99.635. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 99.635. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ99.635TTM99.6350.000
TTM99.635YOY0.108+99.527
TTM99.6355Y20.026+79.609
5Y20.02610Y10.272+9.754
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
MRQ99.6353.009+96.626
TTM99.6353.492+96.143
YOY0.1084.406-4.298
5Y20.0266.688+13.338
10Y10.2728.636+1.636
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of The Biotech Growth Trust PLC.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of The Biotech Growth Trust PLC assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare The Biotech Growth Trust PLC to Asset Management industry mean.
  • A Debt to Asset Ratio of 0.12 means that The Biotech Growth Trust PLC assets are financed with 12.2% credit (debt) and the remaining percentage (100% - 12.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of The Biotech Growth Trust PLC:

  • The MRQ is 0.122. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.122. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.122TTM0.1220.000
TTM0.122YOY0.084+0.038
TTM0.1225Y0.089+0.033
5Y0.08910Y0.079+0.010
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1220.174-0.052
TTM0.1220.165-0.043
YOY0.0840.172-0.088
5Y0.0890.173-0.084
10Y0.0790.177-0.098
4.5.4.2. Debt to Equity Ratio

Measures if The Biotech Growth Trust PLC is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare The Biotech Growth Trust PLC to the Asset Management industry mean.
  • A Debt to Equity ratio of 13.9% means that company has 0.14 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of The Biotech Growth Trust PLC:

  • The MRQ is 0.139. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.139. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.139TTM0.1390.000
TTM0.139YOY0.091+0.047
TTM0.1395Y0.098+0.040
5Y0.09810Y0.087+0.012
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1390.201-0.062
TTM0.1390.195-0.056
YOY0.0910.209-0.118
5Y0.0980.236-0.138
10Y0.0870.242-0.155
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings The Biotech Growth Trust PLC generates.

  • Above 15 is considered overpriced but always compare The Biotech Growth Trust PLC to the Asset Management industry mean.
  • A PE ratio of 4.81 means the investor is paying 4.81 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of The Biotech Growth Trust PLC:

  • The EOD is 4.363. Based on the earnings, the company is cheap. +2
  • The MRQ is 4.807. Based on the earnings, the company is cheap. +2
  • The TTM is 4.807. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.363MRQ4.807-0.444
MRQ4.807TTM4.8070.000
TTM4.807YOY-7.638+12.446
TTM4.8075Y0.843+3.964
5Y0.84310Y1.396-0.553
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
EOD4.3637.530-3.167
MRQ4.8076.853-2.046
TTM4.8076.847-2.040
YOY-7.6384.192-11.830
5Y0.8435.480-4.637
10Y1.3967.031-5.635
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of The Biotech Growth Trust PLC:

  • The EOD is -76.740. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -84.559. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -84.559. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-76.740MRQ-84.559+7.818
MRQ-84.559TTM-84.5590.000
TTM-84.559YOY-53.557-31.001
TTM-84.5595Y-72.923-11.636
5Y-72.92310Y4.387-77.309
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
EOD-76.7405.285-82.025
MRQ-84.5595.059-89.618
TTM-84.5594.707-89.266
YOY-53.5573.256-56.813
5Y-72.9233.660-76.583
10Y4.3872.902+1.485
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of The Biotech Growth Trust PLC is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Asset Management industry mean).
  • A PB ratio of 0.99 means the investor is paying 0.99 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of The Biotech Growth Trust PLC:

  • The EOD is 0.901. Based on the equity, the company is cheap. +2
  • The MRQ is 0.993. Based on the equity, the company is cheap. +2
  • The TTM is 0.993. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.901MRQ0.993-0.092
MRQ0.993TTM0.9930.000
TTM0.993YOY0.955+0.037
TTM0.9935Y0.969+0.023
5Y0.96910Y0.965+0.004
Compared to industry (Asset Management)
PeriodCompanyIndustry (mean)+/- 
EOD0.9010.943-0.042
MRQ0.9930.912+0.081
TTM0.9930.911+0.082
YOY0.9550.931+0.024
5Y0.9691.006-0.037
10Y0.9651.177-0.212
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-03-312021-03-312022-03-312023-03-312024-03-31
Other Current Assets  3,800-3003,5001,4004,900-2,8002,100-1,666,000-1,663,900
Other Current Liabilities  3,380,0001,289,9004,669,900-1,391,1003,278,800-877,6002,401,200-2,417,900-16,700
Net Working Capital  -3,308,400-871,900-4,180,300861,200-3,319,100625,300-2,693,8004,341,0001,647,200



6.2. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets411,420
Total Liabilities50,113
Total Stockholder Equity361,307
 As reported
Total Liabilities 50,113
Total Stockholder Equity+ 361,307
Total Assets = 411,420

Assets

Total Assets411,420
Total Current Assets16,639
Long-term Assets394,754
Total Current Assets
Cash And Cash Equivalents 2,131
Net Receivables 14,508
Total Current Assets  (as reported)16,639
Total Current Assets  (calculated)16,639
+/-0
Long-term Assets
Long Term Investments 394,754
Other Assets 27
Long-term Assets  (as reported)394,754
Long-term Assets  (calculated)394,781
+/- 27

Liabilities & Shareholders' Equity

Total Current Liabilities167
Long-term Liabilities47,078
Total Stockholder Equity361,307
Total Current Liabilities
Short-term Debt 47,078
Accounts payable 167
Other Current Liabilities -167
Total Current Liabilities  (as reported)167
Total Current Liabilities  (calculated)47,078
+/- 46,911
Long-term Liabilities
Long-term Liabilities  (as reported)47,078
Long-term Liabilities  (calculated)0
+/- 47,078
Total Stockholder Equity
Common Stock8,371
Retained Earnings -965
Accumulated Other Comprehensive Income 273,950
Other Stockholders Equity 79,951
Total Stockholder Equity (as reported)361,307
Total Stockholder Equity (calculated)361,307
+/-0
Other
Capital Stock8,371
Cash and Short Term Investments 2,131
Common Stock Shares Outstanding 36,041
Current Deferred Revenue-46,911
Liabilities and Stockholders Equity 411,420
Net Debt 44,947
Net Invested Capital 408,385
Net Working Capital 16,472
Short Long Term Debt Total 47,078



6.3. Balance Sheets Structured

Currency in GBP. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-31
> Total Assets 
34,079
30,743
39,067
80,531
66,467
74,483
132,922
135,198
161,868
266,664
380,434
586,534
425,145
461,495
446,074
431,232
401,189
649,532
427,448
360,509
411,420
411,420360,509427,448649,532401,189431,232446,074461,495425,145586,534380,434266,664161,868135,198132,92274,48366,46780,53139,06730,74334,079
   > Total Current Assets 
331
340
2,024
2,443
1,661
3,227
304
6,852
213
22,293
11,900
3,202
4,582
15
387
60
2,532
6,262
49
3,280
16,639
16,6393,280496,2622,53260387154,5823,20211,90022,2932136,8523043,2271,6612,4432,024340331
       Cash And Cash Equivalents 
289
301
729
0
811
2,161
0
5,691
0
8,401
0
0
0
0
0
0
0
1,502
1,502
2,772
2,131
2,1312,7721,5021,50200000008,40105,69102,1618110729301289
       Net Receivables 
42
39
1,295
2,443
850
1,066
304
1,161
213
13,892
11,900
3,202
4,582
15
387
39
2,494
4,725
4,725
487
14,508
14,5084874,7254,7252,49439387154,5823,20211,90013,8922131,1613041,0668502,4431,2953942
       Other Current Assets 
0
0
0
0
0
0
0
0
0
115
277
138
162
-15
-387
21
38
35
49
21
-16,639
-16,6392149353821-387-15162138277115000000000
   > Long-term Assets 
0
0
37,043
78,088
64,806
71,256
132,618
128,346
161,655
244,296
368,362
583,209
420,427
461,378
445,666
431,172
398,657
643,270
427,399
357,229
394,754
394,754357,229427,399643,270398,657431,172445,666461,378420,427583,209368,362244,296161,655128,346132,61871,25664,80678,08837,04300
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
583,209
420,427
461,378
445,666
431,172
398,657
643,270
427,399
357,229
394,754
394,754357,229427,399643,270398,657431,172445,666461,378420,427583,20900000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
75
172
123
136
102
21
431,232
21
38
35
427,448
27
27427,448353821431,2322110213612317275000000000
> Total Liabilities 
462
294
2,511
3,728
1,970
4,275
12,505
14,380
5,737
22,219
40,186
53,232
46,578
13,083
28,678
22,356
35,616
48,065
33,240
30,218
50,113
50,11330,21833,24048,06535,61622,35628,67813,08346,57853,23240,18622,2195,73714,38012,5054,2751,9703,7282,511294462
   > Total Current Liabilities 
462
294
1,362
2,635
0
1,136
4,016
14,380
5,737
22,219
10,427
1,582
9,340
14,318
5,411
22,356
35,616
48,065
33,240
30,218
167
16730,21833,24048,06535,61622,3565,41114,3189,3401,58210,42722,2195,73714,3804,0161,13602,6351,362294462
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
27,880
48,383
36,189
13,083
22,118
10,841
32,737
26,779
31,741
20,170
47,078
47,07820,17031,74126,77932,73710,84122,11813,08336,18948,38327,8800000000000
       Accounts payable 
462
294
1,362
2,635
0
1,136
4,016
14,380
5,737
22,219
10,427
1,582
9,340
0
5,411
8,570
1,816
1,366
452
6,206
167
1676,2064521,3661,8168,5705,41109,3401,58210,42722,2195,73714,3804,0161,13602,6351,362294462
       Other Current Liabilities 
-462
-294
-1,362
-2,635
0
-1,136
-4,016
-14,380
-5,737
-22,219
-10,427
-1,582
-9,340
1,235
-5,411
13,786
33,800
46,699
32,788
24,012
-167
-16724,01232,78846,69933,80013,786-5,4111,235-9,340-1,582-10,427-22,219-5,737-14,380-4,016-1,1360-2,635-1,362-294-462
   > Long-term Liabilities 
0
0
1,149
1,093
0
3,139
8,489
0
0
0
27,880
48,383
36,189
13,083
22,118
10,841
32,737
26,779
31,741
20,170
47,078
47,07820,17031,74126,77932,73710,84122,11813,08336,18948,38327,8800008,4893,13901,0931,14900
> Total Stockholder Equity
33,617
30,449
36,556
76,803
64,497
70,208
120,417
120,818
156,131
239,616
340,248
533,302
378,567
447,177
417,396
408,876
365,573
601,467
394,208
330,291
361,307
361,307330,291394,208601,467365,573408,876417,396447,177378,567533,302340,248239,616156,131120,818120,41770,20864,49776,80336,55630,44933,617
   Common Stock
7,525
7,525
6,935
16,394
15,596
12,824
16,490
16,239
15,560
16,117
17,222
17,222
15,074
13,960
13,960
12,992
9,802
10,396
10,289
9,684
8,371
8,3719,68410,28910,3969,80212,99213,96013,96015,07417,22217,22216,11715,56016,23916,49012,82415,59616,3946,9357,5257,525
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
124,804
184,701
241,617
282,157
392,122
361,742
353,675
271,167
434,914
412,557
292,310
273,950
273,950292,310412,557434,914271,167353,675361,742392,122282,157241,617184,701124,804000000000
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
26,092
22,924
31,293
62,412
51,174
60,033
106,931
107,924
144,225
26,122
42,566
41,771
43,021
43,021
43,021
-49,776
-51,385
-88,658
79,951
41,970
79,951
79,95141,97079,951-88,658-51,385-49,77643,02143,02143,02141,77142,56626,122144,225107,924106,93160,03351,17462,41231,29322,92426,092



6.4. Balance Sheets

Currency in GBP. All numbers in thousands.




6.5. Cash Flows

Currency in GBP. All numbers in thousands.




6.6. Income Statements

Currency in GBP. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in GBP. All numbers in thousands.

Gross Profit (+$)
totalRevenue77,999
Cost of Revenue-4,639
Gross Profit73,36073,360
 
Operating Income (+$)
Gross Profit73,360
Operating Expense-3,240
Operating Income74,75970,120
 
Operating Expense (+$)
Research Development0
Selling General Administrative3,169
Selling And Marketing Expenses71
Operating Expense3,2403,240
 
Net Interest Income (+$)
Interest Income123
Interest Expense-1,115
Other Finance Cost-0
Net Interest Income-992
 
Pretax Income (+$)
Operating Income74,759
Net Interest Income-992
Other Non-Operating Income Expenses0
Income Before Tax (EBT)74,75976,495
EBIT - interestExpense = 150,139
74,759
75,715
Interest Expense1,115
Earnings Before Interest and Taxes (EBIT)151,25475,874
Earnings Before Interest and Taxes (EBITDA)74,759
 
After tax Income (+$)
Income Before Tax74,759
Tax Provision-159
Net Income From Continuing Ops74,60074,600
Net Income74,600
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,240
Total Other Income/Expenses Net-1,736992
 

Technical Analysis of The Biotech Growth Trust PLC
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of The Biotech Growth Trust PLC. The general trend of The Biotech Growth Trust PLC is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine The Biotech Growth Trust PLC's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of The Biotech Growth Trust PLC.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 907.00 < 944.00 < 949.28.

The bearish price targets are: 868.00 > 851.00 > 827.00.

Tweet this
The Biotech Growth Trust PLC Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of The Biotech Growth Trust PLC. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

The Biotech Growth Trust PLC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of The Biotech Growth Trust PLC. The current macd is -27.58205071.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the The Biotech Growth Trust PLC price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for The Biotech Growth Trust PLC. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the The Biotech Growth Trust PLC price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
The Biotech Growth Trust PLC Daily Moving Average Convergence/Divergence (MACD) ChartThe Biotech Growth Trust PLC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of The Biotech Growth Trust PLC. The current adx is 23.25.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell The Biotech Growth Trust PLC shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
The Biotech Growth Trust PLC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of The Biotech Growth Trust PLC. The current sar is 1,020.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
The Biotech Growth Trust PLC Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of The Biotech Growth Trust PLC. The current rsi is 28.38. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
The Biotech Growth Trust PLC Daily Relative Strength Index (RSI) ChartThe Biotech Growth Trust PLC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of The Biotech Growth Trust PLC. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the The Biotech Growth Trust PLC price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
The Biotech Growth Trust PLC Daily Stochastic Oscillator ChartThe Biotech Growth Trust PLC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of The Biotech Growth Trust PLC. The current cci is -204.97820769.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
The Biotech Growth Trust PLC Daily Commodity Channel Index (CCI) ChartThe Biotech Growth Trust PLC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of The Biotech Growth Trust PLC. The current cmo is -53.06922157.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
The Biotech Growth Trust PLC Daily Chande Momentum Oscillator (CMO) ChartThe Biotech Growth Trust PLC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of The Biotech Growth Trust PLC. The current willr is -89.8089172.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
The Biotech Growth Trust PLC Daily Williams %R ChartThe Biotech Growth Trust PLC Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of The Biotech Growth Trust PLC.

The Biotech Growth Trust PLC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of The Biotech Growth Trust PLC. The current atr is 28.82.

The Biotech Growth Trust PLC Daily Average True Range (ATR) ChartThe Biotech Growth Trust PLC Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of The Biotech Growth Trust PLC. The current obv is 2,293,924.

The Biotech Growth Trust PLC Daily On-Balance Volume (OBV) ChartThe Biotech Growth Trust PLC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of The Biotech Growth Trust PLC. The current mfi is 29.58.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
The Biotech Growth Trust PLC Daily Money Flow Index (MFI) ChartThe Biotech Growth Trust PLC Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for The Biotech Growth Trust PLC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

The Biotech Growth Trust PLC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of The Biotech Growth Trust PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.376
Ma 20Greater thanMa 50995.300
Ma 50Greater thanMa 1001,017.840
Ma 100Greater thanMa 2001,014.850
OpenGreater thanClose887.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of The Biotech Growth Trust PLC with someone you think should read this too:
  • Are you bullish or bearish on The Biotech Growth Trust PLC? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about The Biotech Growth Trust PLC? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about The Biotech Growth Trust PLC

I send you an email if I find something interesting about The Biotech Growth Trust PLC.


Comments

How you think about this?

Leave a comment

Stay informed about The Biotech Growth Trust PLC.

Receive notifications about The Biotech Growth Trust PLC in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.